IRIS
MASTROIANNI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.207
EU - Europa 172
AS - Asia 158
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.540
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.207
SG - Singapore 128
IT - Italia 51
IE - Irlanda 30
RU - Federazione Russa 25
DE - Germania 21
CN - Cina 19
GB - Regno Unito 10
CZ - Repubblica Ceca 8
FI - Finlandia 7
HK - Hong Kong 7
SE - Svezia 6
FR - Francia 5
UA - Ucraina 4
BE - Belgio 2
NL - Olanda 2
AU - Australia 1
BD - Bangladesh 1
EU - Europa 1
IN - India 1
KG - Kirghizistan 1
PL - Polonia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.540
Salva come PNG Salva come JPEG
Città #
Wilmington 440
Houston 277
Singapore 118
Woodbridge 81
Chandler 59
Fairfield 58
New York 25
Rome 25
Santa Clara 25
Ashburn 24
Cambridge 21
Seattle 20
Dublin 18
Ann Arbor 17
Dearborn 11
Medford 11
Beijing 6
Brno 6
Helsinki 6
Hong Kong 6
Lawrence 5
Munich 5
Engelhard 4
Moscow 4
Palo Alto 4
Colorado Springs 3
Guangzhou 3
Jacksonville 3
Palermo 3
San Diego 3
Amsterdam 2
Brussels 2
Council Bluffs 2
Hounslow 2
Leeds 2
Los Angeles 2
Milan 2
Mt. Dora 2
Nanjing 2
North Hollywood 2
Nuremberg 2
Olomouc 2
Pisa 2
Pontedera 2
St. George 2
Wuxi 2
Xi'an 2
Atlanta 1
Bangalore 1
Canberra 1
Central 1
Clearwater 1
Genzano di Roma 1
Johannesburg 1
Kraków 1
Kunming 1
London 1
Nanchang 1
Phoenix 1
Redmond 1
Redwood City 1
San Francisco 1
Taipei 1
Xian 1
Totale 1.342
Salva come PNG Salva come JPEG
Nome #
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 298
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 287
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients 250
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 237
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection 174
Advances in Transcatheter Aortic Valve Therapy in Bicuspid Aortic Valve Disease: Insight into Patient Selection, Management, and Future Directions 40
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 33
Factors influencing place of death and disenrollment among patients receiving specialist palliative care 33
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 25
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 25
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Na{\"i}ve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004?2014 24
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 24
Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 23
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 23
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 21
Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy 19
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 16
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 16
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50~cp/mL 13
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 12
The Wounded Healer: A Phenomenological Study on Hospital Nurses Who Contracted COVID-19 8
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 5
Totale 1.606
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.117
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020351 0 0 0 0 39 59 52 45 51 36 32 37
2020/2021263 27 32 27 37 28 31 27 32 7 7 4 4
2021/202269 1 5 3 3 7 3 7 4 12 5 5 14
2022/2023129 5 10 16 10 17 23 12 15 7 7 4 3
2023/2024145 16 5 3 1 9 19 0 4 6 59 1 22
2024/2025259 17 128 63 36 15 0 0 0 0 0 0 0
Totale 1.606